1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. South Africa >
  5. Cipla Acquires Enaleni Pharmaceuticals

M&A Deal Summary

Cipla Acquires Enaleni Pharmaceuticals

On February 27, 2013, Cipla acquired life science company Enaleni Pharmaceuticals for 4.5B ZAR

Acquisition Highlights
  • This is Cipla’s 1st transaction in the Life Science sector.
  • This is Cipla’s 0th largest (disclosed) transaction.
  • This is Cipla’s 1st transaction in South Africa.

M&A Deal Summary
Date 2013-02-27
Target Enaleni Pharmaceuticals
Sector Life Science
Buyer(s) Cipla
Deal Type Add-on Acquisition
Deal Value 4.5B ZAR

Target

Enaleni Pharmaceuticals

Cape Town, South Africa
Enaleni Pharmaceuticals Ltd. (Medpro) is one of South Africa's fastest growing pharmaceutical companies. The  third largest pharmaceutical firm in SA, it is a major provider of chronic medicines to the public and private sectors, with particular strength within, inter alia, the cardiovascular, antiretroviral (ARV), respiratory and neuropsychiatric categories. Medpro has 2 distribution centers in Cape Town, one in Durbanville and one in Atlas Gardens.

Search 215,029 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Cipla

Mumbai, India
Category Company
Founded 1935
Sector Life Science
Employees30,313
Revenue 271.5B INR (2025)
DESCRIPTION

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. Cipla was founded in 1935 and is based in Mumbai, Maharashtra.

DEAL STATS #
Overall 1 of 6
Sector: Life Science M&A 1 of 4
Type: Add-on Acquisition M&A Deals 1 of 4
Country: South Africa M&A 1 of 2
Year: 2013 M&A 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-09-03 InvaGen Pharmaceuticals

Hauppauge, New York, United States

InvaGen Pharmaceuticals, Inc. is a generic pharmaceutical company in the US. InvaGen is engaged in development, manufacturing, marketing and distributing of generic pharmaceuticals with focus on wide range of therapeutic areas including, cardiovascular, anti-infective, CNS, anti-inflammatory, anti-diabetic and anti-depressants.

Buy -
Mergr

Solution for

Product

Company

Legal